• Theme Breast Cancer
  • Resource Type Position Statement
  • DATE 31 December 2014

The role of single nucleotide polymorphisms (SNP) testing for personalised breast cancer risk prediction

This document is a joint position statement from COSA, the Human Genetics Society of Australasia (HGSA), the Royal College of Pathologists of Australasia (RCPA), and the Royal Australian College of General Practitioners (RACGP) on the role of single nucleotide polymorphisms (SNP) testing for personalised breast cancer risk prediction.

    • What is SNP testing?
    • The availability of SNP testing for breast cancer risk
    • Points to consider around SNP testing for breast cancer risk

Download  download pdf